Quote:

---

And I'm not sure why the FDA wouldn't choose her once again to head the team to respond to any and all CYDY submissions, since she has had experience with the company and the drug.

---

The release of what Strayhorn was doing in regards to Cytodyn was a black eye to the FDA. They wouldn't dare keep her on Cytodyn's case. Being a civil servant unfortunately it would be an uphill battle for the FDA to fire her.